An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer

Authors

Jelle Wesseling, Corrado Tinterri, Anna Sapino, Fabrizio Zanconati, Martijn Lutke-Holzik, Bichlien Nguyen, Kenneth B Deck, Patrizia Querzoli, Tiziana Perin, Carmela Giardina, Gerhard Seitz, Jean-Marc Guinebretière, Julie Barone, Laura Dekker, Femke de Snoo, Lisette Stork-Sloots, Paul Roepman, Toru Watanabe, Pino Cusumano